Joshua D. Bromley, Sharie Keanne C. Ganchua, Sarah K. Nyquist, Pauline Maiello, Michael Chao, H. Jacob Borish, Mark Rodgers, Jaime Tomko, Kara Kracinovsky, Douaa Mugahid, Son Nguyen, Qianchang Dennis Wang, Jacob M. Rosenberg, Edwin C. Klein, Hannah P. Gideon, Roisin Floyd-O’Sullivan, Bonnie Berger, Charles A. Scanga, Philana Ling Lin, Sarah M. Fortune, JoAnne L. Flynn
{"title":"CD4+ T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection","authors":"Joshua D. Bromley, Sharie Keanne C. Ganchua, Sarah K. Nyquist, Pauline Maiello, Michael Chao, H. Jacob Borish, Mark Rodgers, Jaime Tomko, Kara Kracinovsky, Douaa Mugahid, Son Nguyen, Qianchang Dennis Wang, Jacob M. Rosenberg, Edwin C. Klein, Hannah P. Gideon, Roisin Floyd-O’Sullivan, Bonnie Berger, Charles A. Scanga, Philana Ling Lin, Sarah M. Fortune, JoAnne L. Flynn","doi":"10.1016/j.immuni.2024.08.002","DOIUrl":null,"url":null,"abstract":"<p>Immunological priming—in the context of either prior infection or vaccination—elicits protective responses against subsequent <em>Mycobacterium tuberculosis</em> (<em>Mtb</em>) infection. However, the changes that occur in the lung cellular milieu post-primary <em>Mtb</em> infection and their contributions to protection upon reinfection remain poorly understood. Using clinical and microbiological endpoints in a non-human primate reinfection model, we demonstrated that prior <em>Mtb</em> infection elicited a long-lasting protective response against subsequent <em>Mtb</em> exposure and was CD4<sup>+</sup> T cell dependent. By analyzing data from primary infection, reinfection, and reinfection-CD4<sup>+</sup> T cell-depleted granulomas, we found that the presence of CD4<sup>+</sup> T cells during reinfection resulted in a less inflammatory lung milieu characterized by reprogrammed CD8<sup>+</sup> T cells, reduced neutrophilia, and blunted type 1 immune signaling among myeloid cells. These results open avenues for developing vaccines and therapeutics that not only target lymphocytes but also modulate innate immune cells to limit tuberculosis (TB) disease.</p>","PeriodicalId":13269,"journal":{"name":"Immunity","volume":"125 1","pages":""},"PeriodicalIF":25.5000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2024.08.002","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Immunological priming—in the context of either prior infection or vaccination—elicits protective responses against subsequent Mycobacterium tuberculosis (Mtb) infection. However, the changes that occur in the lung cellular milieu post-primary Mtb infection and their contributions to protection upon reinfection remain poorly understood. Using clinical and microbiological endpoints in a non-human primate reinfection model, we demonstrated that prior Mtb infection elicited a long-lasting protective response against subsequent Mtb exposure and was CD4+ T cell dependent. By analyzing data from primary infection, reinfection, and reinfection-CD4+ T cell-depleted granulomas, we found that the presence of CD4+ T cells during reinfection resulted in a less inflammatory lung milieu characterized by reprogrammed CD8+ T cells, reduced neutrophilia, and blunted type 1 immune signaling among myeloid cells. These results open avenues for developing vaccines and therapeutics that not only target lymphocytes but also modulate innate immune cells to limit tuberculosis (TB) disease.
在先前感染或接种疫苗的情况下,免疫启动可引起对结核分枝杆菌(Mtb)后续感染的保护性反应。然而,人们对初次Mtb感染后肺部细胞环境发生的变化及其对再感染时的保护作用仍知之甚少。通过在非人灵长类动物再感染模型中使用临床和微生物学终点,我们证明了之前的Mtb感染会对随后的Mtb暴露产生持久的保护性反应,并且依赖于CD4+ T细胞。通过分析原发感染、再感染和再感染-CD4+ T 细胞贫化肉芽肿的数据,我们发现再感染期间 CD4+ T 细胞的存在导致肺部环境炎症性降低,其特点是 CD8+ T 细胞重编程、中性粒细胞增多减少以及髓系细胞中 1 型免疫信号转导减弱。这些结果为开发不仅针对淋巴细胞,而且还能调节先天性免疫细胞以限制结核病(TB)的疫苗和疗法开辟了道路。
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.